Dr Steve Shillitoe
In August 2018, I joined the Division of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine as a Research Software Engineer working on the TRISTAN (TRanslational Imaging in Drug SafeTy AssessmeNt) project. The TRISTAN project aims to validate translational imaging methods as potential imaging biomarkers for prevention, mitigation and management of drug-induced harm to patients. My role in this project is to develop software that will allow the kinetic profiling of the hepatic uptake and efflux transporters that mediate hepatic uptake and biliary excretion of the contrast agent gadoxetate.
TRISTAN - The use of imaging techniques with "biomarkers" to improve drug safety analysis. This will help drug developers to bring new, safer drugs to the market and thereby enable doctors to treat their patients more effectively.
- PhD Chemical Engineering, University of Bradford.
- PGCE Secondary IT and Mathematics
- MSc Computer Science, Queen's University of Belfast
- BSc Metallurgy, Sheffield Hallam University
Research groups and institutes
- Leeds Institute of Cardiovascular and Metabolic Medicine